[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368663-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368663-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","nostoc-commune-derived-scytonemin-induced-mitochondrial-cell-death-in-leukemia-models","Nostoc commune-derived scytonemin induced mitochondrial cell death in leukemia models","","Cyanobacteria have long been explored as sources for new cancer therapies. This study evaluates the antiproliferative effects of Nostoc commune extract (NOS) and scytonemin (SCY) across multiple in vitro cancer cell lines, including cervix, colon, breast, lung, and leukemia, using resazurin assays. Both compounds reduced metabolic activity in a dose-dependent manner, with SCY showing stronger inhibition than NOS, especially in HL-60 and Jurkat leukemia cells. SCY treatment triggered cell cycle arrest, apoptosis markers, mitochondrial dysfunction, cytochrome c release, caspase activation, and PARP cleavage, indicating mitochondrial-pathway apoptosis in leukemia cells and supporting future development as an anticancer agent.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/nostoc-commune-derived-scytonemin-induced-mitochondrial-cell-death-in-leukemia-models/368663/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/nostoc-commune-derived-scytonemin-induced-mitochondrial-cell-death-in-leukemia-models/368663.png","ImageObject",300,407,{"name":42,"@type":43},"Terk","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What compounds were tested in the leukemia models study?","Question",{"text":63,"@type":64},"The study tested Nostoc commune extract (NOS) and the cyanobacterial compound scytonemin (SCY). Their effects were evaluated across multiple in vitro cancer models, including leukemia cell lines.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did SCY and NOS affect cancer cell growth or activity?",{"text":68,"@type":64},"Both NOS and SCY inhibited metabolic activity in a dose-dependent manner, but SCY showed higher inhibitory activity across the tested cancer models. The strongest effects were observed in HL-60 and Jurkat leukemia cells.",{"name":70,"@type":61,"acceptedAnswer":71},"What mechanism did SCY use to induce cell death in leukemia cells?",{"text":72,"@type":64},"SCY induced mitochondrial-pathway apoptosis, shown by cell cycle arrest/apoptosis indicators, reduced mitochondrial membrane potential, cytochrome c release, activation of caspase-9 and downstream caspases, and PARP cleavage.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368663,1790531720,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},1099525198933,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Medical Oncology (2025) 42:341  \n[https://doi.org/10.1007/s12032-025-02890-3](https://doi.org/10.1007/s12032-025-02890-3)  \nNostoc commune‑derived scytonemin induced mitochondrial cell death in leukemia models  \nSimona Zilakova1 · Martina Gavurova2 · Dominika Sebova1 · Michal Goga2,4 · Martin Backor2,3 · Viktoria Medvecova1 · Dajana Kecsey2 · Martin Kello1  \nReceived: 9 April 2025 / Accepted: 25 June 2025 / Published online: 17 July 2025 © The Author(s) 2025  \nAbstract  \nCyanobacteria have long attracted scientific interest through their potential application in the development of new therapeutic approaches, particularly those related to the treatment of cancer. In this study, the antiproliferative effects of Nostoc commune extract (NOS) and the cyanobacterial compound scytonemin (SCY) were evaluated against a variety of in vitro cancer models, including cervix, colon, breast, lung, and leukemia cell lines, using resazurin assays. Both of the studied compounds were found to have inhibited metabolic activity in a dose-dependent manner, with IC50 values ranging from 60.5 to 462.0 µM for SCY and 157.0 to 740.3 µM for NOS. SCY displayed higher levels of inhibitory activity than NOS against all of the tested cancer models, but was particularly effective against HL-60 and Jurkat leukemia cells, with IC50 values recorded as 60.5 µMand 88.2 µM, respectively. However in contrast, the two compounds exhibited significantly lower levels of inhibition against non-cancerous MCF-10A and BJ-5ta cells. Flow cytometry studies of leukemia cells treated with SCY revealed that the compound had effectively inhibited cell proliferation over prolonged periods; HL-60 cells displayed G1 phase arrest which lasted for 48 h, while an accumulated G0/G1 sub-population was detected in Jurkat cells, as indicator of apoptosis. Further analysis of cells treated with SCY observed reduced levels of Rb protein and an increase in p21 expression in both HL-60 and Jurkat cell lines. Apoptotic markers such as phosphatidylserine externalization were observed, and mitochondrial dysfunction characterized by the dissipation of mitochondrial membrane potential was also detected. SCY activated the mitochondrial apoptotic pathway, inducing cytochrome c release and subsequent caspase-9, -3, and-7 activation. Finally, PARP cleavage, a typical marker of apoptosis, was identified in both leukemia cell lines following treatment with SCY. The findings suggest that SCY induces apoptosis in leukemia cells through the activation of the mitochondrial pathway, highlighting its potential for development as a future anti-cancer agent.  \nKeywords Scytonemin · Apoptosis · Signal pathways · Tumor · Cancer  \nIntroduction  \nAccording to the most recent data available from the GLOBOCAN database, leukemia was the second most common hematological malignancy worldwide in 2022, with only non-Hodgkin lymphoma being diagnosed more frequently. Acute myeloid leukemia is the most prevalent form in adults, whereas acute lymphoblastic leukemia is the most common type among children [1] . Various factors can limit the success of conventional anticancer therapies, such as the heterogeneous nature of tumors, the development of drug  \nSimona Zilakova and Martina Gavurova contributed equally.  \nExtended author information available on the last page of the article  \nresistance, or the occurrence of severe adverse effects. To improve survival rates and improve the quality of life for patients without compromising treatment efficacy unduly, there is a clear need to identify and develop new therapeutic strategies which are less susceptible to the limitations posed by these factors [2] .  \nRecent decades have seen a growing scientific interest in the use of natural products in the development of innovative anticancer agents [3] . More than half of currently available anticancer drugs are derived from plants, marine invertebrates, or microorganisms [4, 5] . One group which has attracted particular interest in pharm","cbCaiqibYKYhieNK","https://ap.wps.com/l/cbCaiqibYKYhieNK","pdf",2232536,17,"English","# Abstract\n# Keywords\n# Introduction","[{\"question\":\"What compounds were tested in the leukemia models study?\",\"answer\":\"The study tested Nostoc commune extract (NOS) and the cyanobacterial compound scytonemin (SCY). Their effects were evaluated across multiple in vitro cancer models, including leukemia cell lines.\"},{\"question\":\"How did SCY and NOS affect cancer cell growth or activity?\",\"answer\":\"Both NOS and SCY inhibited metabolic activity in a dose-dependent manner, but SCY showed higher inhibitory activity across the tested cancer models. The strongest effects were observed in HL-60 and Jurkat leukemia cells.\"},{\"question\":\"What mechanism did SCY use to induce cell death in leukemia cells?\",\"answer\":\"SCY induced mitochondrial-pathway apoptosis, shown by cell cycle arrest/apoptosis indicators, reduced mitochondrial membrane potential, cytochrome c release, activation of caspase-9 and downstream caspases, and PARP cleavage.\"}]","Nostoc commune-derived scytonemin induced mitochondrial cell death in leukemia models | PDF",1790177918,43,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e604b839597ee6b2126db800256c1a61.webp",983,1305,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/12143732ce1061b7427b7f74a98f3b92.webp",982,1304,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/19afdf814327596c42a4e17567a8c39b.webp",981,1303,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f45d6a646f7422be2c76048fb21db9db.webp",980,1301]